BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 8221053)

  • 1. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease.
    Owen AM; Roberts AC; Hodges JR; Summers BA; Polkey CE; Robbins TW
    Brain; 1993 Oct; 116 ( Pt 5)():1159-75. PubMed ID: 8221053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fronto-striatal cognitive deficits at different stages of Parkinson's disease.
    Owen AM; James M; Leigh PN; Summers BA; Marsden CD; Quinn NP; Lange KW; Robbins TW
    Brain; 1992 Dec; 115 ( Pt 6)():1727-51. PubMed ID: 1486458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying attentional set-shifting in Parkinson's disease.
    Gauntlett-Gilbert J; Roberts RC; Brown VJ
    Neuropsychologia; 1999 May; 37(5):605-16. PubMed ID: 10340319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological evidence for frontostriatal dysfunction in schizophrenia.
    Elliott R; McKenna PJ; Robbins TW; Sahakian BJ
    Psychol Med; 1995 May; 25(3):619-30. PubMed ID: 7480441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Researching a differential impairment of frontal functions and explicit memory in early Parkinson's disease.
    Farina E; Gattellaro G; Pomati S; Magni E; Perretti A; Cannatà AP; Nichelli P; Mariani C
    Eur J Neurol; 2000 May; 7(3):259-67. PubMed ID: 10886309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction.
    Robbins TW; James M; Owen AM; Lange KW; Lees AJ; Leigh PN; Marsden CD; Quinn NP; Summers BA
    J Neurol Neurosurg Psychiatry; 1994 Jan; 57(1):79-88. PubMed ID: 8301310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disturbed frontal regulation of attention in Parkinson's disease.
    Stam CJ; Visser SL; Op de Coul AA; De Sonneville LM; Schellens RL; Brunia CH; de Smet JS; Gielen G
    Brain; 1993 Oct; 116 ( Pt 5)():1139-58. PubMed ID: 8221052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man.
    Owen AM; Roberts AC; Polkey CE; Sahakian BJ; Robbins TW
    Neuropsychologia; 1991; 29(10):993-1006. PubMed ID: 1762678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slowing of reaction time in Parkinson's disease: the involvement of the frontal lobes.
    Berry EL; Nicolson RI; Foster JK; Behrmann M; Sagar HJ
    Neuropsychologia; 1999 Jun; 37(7):787-95. PubMed ID: 10408646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction.
    Lange KW; Robbins TW; Marsden CD; James M; Owen AM; Paul GM
    Psychopharmacology (Berl); 1992; 107(2-3):394-404. PubMed ID: 1615139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Learning to be inflexible: Enhanced attentional biases in Parkinson's disease.
    Fallon SJ; Hampshire A; Barker RA; Owen AM
    Cortex; 2016 Sep; 82():24-34. PubMed ID: 27318659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of learned irrelevance in attentional set-shifting impairments in Parkinson's disease.
    Slabosz A; Lewis SJ; Smigasiewicz K; Szymura B; Barker RA; Owen AM
    Neuropsychology; 2006 Sep; 20(5):578-88. PubMed ID: 16938020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perseveration for novel stimuli in Parkinson's disease: an evaluation based on event-related potentials topography.
    Hozumi A; Hirata K; Tanaka H; Yamazaki K
    Mov Disord; 2000 Sep; 15(5):835-42. PubMed ID: 11009188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired novelty detection and frontal lobe dysfunction in Parkinson's disease.
    Tsuchiya H; Yamaguchi S; Kobayashi S
    Neuropsychologia; 2000; 38(5):645-54. PubMed ID: 10689041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal aging and Parkinson's disease are associated with the functional decline of distinct frontal-striatal circuits.
    Gruszka A; Hampshire A; Barker RA; Owen AM
    Cortex; 2017 Aug; 93():178-192. PubMed ID: 28667892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbances in higher function in Parkinson's disease.
    Tamaru F
    Eur Neurol; 1997; 38 Suppl 2():33-6. PubMed ID: 9387801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A specific shifting deficit in Parkinson's disease: a reversal shift of consistent stimulus-response mappings.
    Hsieh S; Chuang YY; Hwang WJ; Pai MC
    Percept Mot Skills; 1998 Dec; 87(3 Pt 1):1107-19. PubMed ID: 9885083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic effects on cognitive performance in patients with Parkinson's disease.
    Lange KW; Paul GM; Naumann M; Gsell W
    J Neural Transm Suppl; 1995; 46():423-32. PubMed ID: 8821078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Object alternation and orbitofrontal system dysfunction in Alzheimer's and Parkinson's disease.
    Freedman M
    Brain Cogn; 1990 Nov; 14(2):134-43. PubMed ID: 2285509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired dimensional selection but intact use of reward feedback during visual discrimination learning in Parkinson's disease.
    Swainson R; SenGupta D; Shetty T; Watkins LH; Summers BA; Sahakian BJ; Polkey CE; Barker RA; Robbins TW
    Neuropsychologia; 2006; 44(8):1290-304. PubMed ID: 16529779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.